These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22262480)

  • 21. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats.
    Philipp S; Jürgensen JS; Fielitz J; Bernhardt WM; Weidemann A; Schiche A; Pilz B; Dietz R; Regitz-Zagrosek V; Eckardt KU; Willenbrock R
    Eur J Heart Fail; 2006 Jun; 8(4):347-54. PubMed ID: 16513418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism.
    Madai S; Kilic P; Schmidt RM; Bas-Orth C; Korff T; Büttner M; Klinke G; Poschet G; Marti HH; Kunze R
    Theranostics; 2024; 14(7):2856-2880. PubMed ID: 38773968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1alpha Pro-564 hydroxylation.
    D'Angelo G; Duplan E; Vigne P; Frelin C
    J Biol Chem; 2003 Apr; 278(17):15406-11. PubMed ID: 12586829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point.
    Khanna S; Roy S; Maurer M; Ratan RR; Sen CK
    Free Radic Biol Med; 2006 Jun; 40(12):2147-54. PubMed ID: 16785028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase.
    Nangaku M; Kojima I; Tanaka T; Ohse T; Kato H; Fujita T
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):129-39. PubMed ID: 18221080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury.
    Kapitsinou PP; Sano H; Michael M; Kobayashi H; Davidoff O; Bian A; Yao B; Zhang MZ; Harris RC; Duffy KJ; Erickson-Miller CL; Sutton TA; Haase VH
    J Clin Invest; 2014 Jun; 124(6):2396-409. PubMed ID: 24789906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
    Appelhoff RJ; Tian YM; Raval RR; Turley H; Harris AL; Pugh CW; Ratcliffe PJ; Gleadle JM
    J Biol Chem; 2004 Sep; 279(37):38458-65. PubMed ID: 15247232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
    Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
    Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.
    Lee DW; Rajagopalan S; Siddiq A; Gwiazda R; Yang L; Beal MF; Ratan RR; Andersen JK
    J Biol Chem; 2009 Oct; 284(42):29065-76. PubMed ID: 19679656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolyl hydroxylases and therapeutics.
    Smith TG; Talbot NP
    Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
    Alcaide-German ML; Vara-Vega A; Garcia-Fernandez LF; Landazuri MO; del Peso L
    BMC Cell Biol; 2008 Apr; 9():18. PubMed ID: 18402654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.
    Siddiq A; Aminova LR; Ratan RR
    Neurochem Res; 2007; 32(4-5):931-46. PubMed ID: 17342411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypoxia-inducible factor-α prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A.
    Ike T; Doi S; Nakashima A; Sasaki K; Ishiuchi N; Asano T; Masaki T
    Am J Physiol Renal Physiol; 2022 Nov; 323(5):F539-F552. PubMed ID: 36074918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
    Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
    J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment.
    Oyaizu-Toramaru T; Suhara T; Hayakawa N; Nakamura T; Kubo A; Minamishima S; Yamaguchi K; Hishiki T; Morisaki H; Suematsu M; Minamishima YA
    Mol Cell Biol; 2017 Aug; 37(16):. PubMed ID: 28606929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
    Nangaku M; Izuhara Y; Takizawa S; Yamashita T; Fujii-Kuriyama Y; Ohneda O; Yamamoto M; van Ypersele de Strihou C; Hirayama N; Miyata T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2548-54. PubMed ID: 17932321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel therapeutic approach targeting the HIF-HRE system in the kidney.
    Nangaku M
    Adv Exp Med Biol; 2009; 645():81-6. PubMed ID: 19227454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
    Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
    FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.